title: Tissue-type plasminogen activator (t-PA) and dilute blood clot lysis time in nephrotic patients.
abstract: When compared to normal weight normolipidemic control subjects, dilute blood clot lysis time was found to be obviously (p less than 0.001) prolonged in hypertriglyceridemic patients without proteinuria and slightly (p less than 0.05) accelerated in hyperlipidemic nephrotic patients in spite of their very high levels of plasma fibrinogen. As a result the ratio plasma fibrinogen (mg/dl) per clot lysis time (minutes) was 1.241 +/- 0.08 (X +/- SEM) in control subjects, 0.574 +/- 0.07 in hypertriglyceridemic patients and 2.69 +/- 0.172 in nephrotic patients. This finding suggesting that a larger amount of fibrin is rather readily dispersed from dilute blood clots of nephrotic patients was associated with higher levels of plasma t-PA:Ag (9.45 ng/ml +/- 1.18 in nephrotic patients versus 5.8 ng/ml +/- 1.23 in controls before venous occlusion and respectively 33.1 ng/ml +/- 3.83 versus 20.3 +/- 3.40 in controls after venous occlusion). Plasminogen activator activity of the euglobulins as assessed by the bovine fibrin-agarose plate was significantly higher in nephrotic patients only after venous occlusion. Plasma samples of nephrotic patients exerted a more potent inhibition of fibrinolysis in a urokinase activated system. This effect was, however, mainly due to the high levels of alpha 2 macroglobulin in nephrotic plasma which apparently have little influence on dilute blood clot lysis time.
authors.affiliation: Medical Clinic N.I., Cluj-Napoca, Romania.
authors.forename: M P
authors.initials: MP
authors.lastname: Cucuianu
authors.forename: H G
authors.initials: HG
authors.lastname: Rus
authors.forename: S
authors.initials: S
authors.lastname: Roman
authors.forename: C
authors.initials: C
authors.lastname: Mărcuşu
authors.forename: C
authors.initials: C
authors.lastname: Spînu
authors.forename: M
authors.initials: M
authors.lastname: Manasia
authors.forename: F
authors.initials: F
authors.lastname: Niculescu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000941:Antigens / Q000032:analysis; D001780:Blood Coagulation Tests; D002784:Cholesterol / Q000097:blood; D002802:Cholinesterases / Q000097:blood; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood; D008297:Male; D008875:Middle Aged; D009401:Nephrosis / Q000097:blood*; D010959:Tissue Plasminogen Activator / Q000032:analysis* / Q000276:immunology; D014280:Triglycerides / Q000097:blood
chemical_list: D000941:Antigens; D014280:Triglycerides; D005340:Fibrinogen; D002784:Cholesterol; D002802:Cholinesterases; D010959:Tissue Plasminogen Activator